The offer for Medivation follows CEO Olivier Brandicourt's reorganization (Also see " Brandicourt's 'Big Reveal' Falls Flat For Sanofi " - Scrip, 10 November, 2015.) of Sanofi in which oncology is one of the businesses where he plans to build a competitive position.
Sanofi says it made a non-binding proposal to acquire San Francisco-based Medivation Inc. for $52.50 per share, an all-cash transaction...


![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

